LORELIN 3.75 mg Lorelin 3.75 mg Injection (Leuprorelin Acetate) is a prescription hormone therapy that reduces hormone production by the pituitary gland. It belongs to a class of GnRH analogues and is widely used in the treatment of advanced prostate cancer, endometriosis, uterine fibroids, central precocious puberty, and select hormone-sensitive cancers. The 3.75 mg depot formulation provides sustained hormone suppression over approximately one month and is administered as a single intramuscular or subcutaneous injection by healthcare professionals. Patients require ongoing medical supervision due to potential side effects, hormone changes, and treatment monitoring. This medication typically requires a doctor’s prescription.